Self-care Management Intervention in Heart Failure (SMART-HF) : A Multicenter Randomized Controlled Trial
Sahlin, DANIEL ; REZANEZAD, BABAK ; EDVINSSON, MARIE LOUISE LU ; BACHUS, ERASUMS ; MELANDER, O. LU
and GERWARD, SOFIA
LU
(2022)
In Journal of Cardiac Failure
28(1).
p.3-12
- Abstract
Background: Self-care behavior is important in avoiding hospitalization for patients with heart failure (HF) and refers to those activities performed with the intention of improving or restoring health and well-being, as well as treating or preventing disease. The purpose was to study the effects of a home-based mobile device on self-care behavior and hospitalizations in a representative HF-population. Methods and Results: SMART-HF is a randomized controlled multicenter clinical trial, where patients were randomized 1:1 to receive standard care (control group [CG]) or intervention with a home-based tool designed to enhance self-care behavior (intervention group [IG]) and followed for 240 days. The tool educates the patient about HF,... (More)
Background: Self-care behavior is important in avoiding hospitalization for patients with heart failure (HF) and refers to those activities performed with the intention of improving or restoring health and well-being, as well as treating or preventing disease. The purpose was to study the effects of a home-based mobile device on self-care behavior and hospitalizations in a representative HF-population. Methods and Results: SMART-HF is a randomized controlled multicenter clinical trial, where patients were randomized 1:1 to receive standard care (control group [CG]) or intervention with a home-based tool designed to enhance self-care behavior (intervention group [IG]) and followed for 240 days. The tool educates the patient about HF, monitors objective and subjective symptoms and adjusts loop diuretics. The primary outcome is self-care as measured by the European Heart Failure Self-care behavior scale and the secondary outcome is HF related in-hospital days.A total of 124 patients were recruited and 118 were included in the analyses (CG: n = 60, IG: n = 58). The mean age was 79 years, 39% were female, and 45% had an ejection fraction of less than 40%. Self-care was significantly improved in the IG compared to the CG (median (interquartile range) (21.5 [13.25; 28] vs 26 [18; 29.75], p = 0.014). Patients in the IG spent significantly less time in the hospital admitted for HF (2.2 days less, relative risk 0.48, 95% confidence interval 0.32–0.74, P = .001). Conclusions: The device significantly improved self-care behavior and reduced in-hospital days in a relevant HF population.
(Less)
- author
- Sahlin, DANIEL
; REZANEZAD, BABAK
; EDVINSSON, MARIE LOUISE
LU
; BACHUS, ERASUMS
; MELANDER, O.
LU
and GERWARD, SOFIA
LU
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Cardiac Failure
- volume
- 28
- issue
- 1
- pages
- 3 - 12
- publisher
- Elsevier
- external identifiers
-
- pmid:34161807
- scopus:85111104159
- ISSN
- 1071-9164
- DOI
- 10.1016/j.cardfail.2021.06.009
- project
- MOVING FROM BIOMARKERS TO MECHANISM ORIENTED PREVENTION OF CARDIOMETABOLIC DISEASE
- language
- English
- LU publication?
- yes
- id
- e4f78de9-af23-4748-be81-a5da3f1a59f0
- date added to LUP
- 2021-12-22 08:58:26
- date last changed
- 2024-06-15 23:25:19
@article{e4f78de9-af23-4748-be81-a5da3f1a59f0,
abstract = {{<p>Background: Self-care behavior is important in avoiding hospitalization for patients with heart failure (HF) and refers to those activities performed with the intention of improving or restoring health and well-being, as well as treating or preventing disease. The purpose was to study the effects of a home-based mobile device on self-care behavior and hospitalizations in a representative HF-population. Methods and Results: SMART-HF is a randomized controlled multicenter clinical trial, where patients were randomized 1:1 to receive standard care (control group [CG]) or intervention with a home-based tool designed to enhance self-care behavior (intervention group [IG]) and followed for 240 days. The tool educates the patient about HF, monitors objective and subjective symptoms and adjusts loop diuretics. The primary outcome is self-care as measured by the European Heart Failure Self-care behavior scale and the secondary outcome is HF related in-hospital days.A total of 124 patients were recruited and 118 were included in the analyses (CG: n = 60, IG: n = 58). The mean age was 79 years, 39% were female, and 45% had an ejection fraction of less than 40%. Self-care was significantly improved in the IG compared to the CG (median (interquartile range) (21.5 [13.25; 28] vs 26 [18; 29.75], p = 0.014). Patients in the IG spent significantly less time in the hospital admitted for HF (2.2 days less, relative risk 0.48, 95% confidence interval 0.32–0.74, P = .001). Conclusions: The device significantly improved self-care behavior and reduced in-hospital days in a relevant HF population.</p>}},
author = {{Sahlin, DANIEL and REZANEZAD, BABAK and EDVINSSON, MARIE LOUISE and BACHUS, ERASUMS and MELANDER, O. and GERWARD, SOFIA}},
issn = {{1071-9164}},
language = {{eng}},
number = {{1}},
pages = {{3--12}},
publisher = {{Elsevier}},
series = {{Journal of Cardiac Failure}},
title = {{Self-care Management Intervention in Heart Failure (SMART-HF) : A Multicenter Randomized Controlled Trial}},
url = {{http://dx.doi.org/10.1016/j.cardfail.2021.06.009}},
doi = {{10.1016/j.cardfail.2021.06.009}},
volume = {{28}},
year = {{2022}},
}